Skip to main content

Table 2 Patient Characteristics

From: Initial partial response and stable disease according to RECIST indicate similar survival for chemotherapeutical patients with advanced non-small cell lung cancer

  Response after 2 courses of platinum-based chemotherapy
  PR (n = 37) (%) SD (n = 117) (%) P
Age, year, median 56 57 0.286
Sex, %    
   Female 15(41%) 47(40%) 0.968
   Male 22(59%) 70(60%)  
Stage, %    
   IIIB 13(35%) 44(38%) 0.786
   IV 24(65%) 73(62%)  
ECOG performance status, %    
   0 25(68%) 59(50%) 0.068
   1 12(32%) 58(50%)  
Weight loss ≥5%, % 14(38%) 50(43%) 0.598
  1. PR Partial Response; SD Stable Disease; ECOG Eastern Cooperative Oncology Group.